Published in Infect Immun on December 01, 1985
Molecular mechanism and physiological functions of clathrin-mediated endocytosis. Nat Rev Mol Cell Biol (2011) 6.32
Domain swapping: entangling alliances between proteins. Proc Natl Acad Sci U S A (1994) 4.20
Refined structure of dimeric diphtheria toxin at 2.0 A resolution. Protein Sci (1994) 1.88
Ultrastructural study of endocytosis of Chlamydia trachomatis by McCoy cells. Infect Immun (1988) 1.87
Ultrastructural study of mode of entry of Chlamydia psittaci into L-929 cells. Infect Immun (1986) 1.85
Refined structure of monomeric diphtheria toxin at 2.3 A resolution. Protein Sci (1994) 1.64
Characterization of rabbit ileal receptors for Clostridium difficile toxin A. Evidence for a receptor-coupled G protein. J Clin Invest (1991) 1.34
Purification of the Clostridium spiroforme binary toxin and activity of the toxin on HEp-2 cells. Infect Immun (1989) 1.32
Diphtheria toxin at low pH depolarizes the membrane, increases the membrane conductance and induces a new type of ion channel in Vero cells. EMBO J (1994) 1.12
Pathogenesis of Shigella diarrhea: rabbit intestinal cell microvillus membrane binding site for Shigella toxin. Infect Immun (1986) 1.06
Characterization of a cellular protease that cleaves Pseudomonas exotoxin. Infect Immun (1992) 1.01
Reduced temperature alters Pseudomonas exotoxin A entry into the mouse LM cell. Infect Immun (1986) 1.00
Expression of functional diphtheria toxin receptors on highly toxin-sensitive mouse cells that specifically bind radioiodinated toxin. Proc Natl Acad Sci U S A (1992) 0.93
Isolation of diphtheria toxin-sensitive mouse cells from a toxin-resistant population transfected with monkey DNA. Proc Natl Acad Sci U S A (1990) 0.90
Azurophilic granules of human neutrophils contain CD14. Infect Immun (1997) 0.85
Anthrax edema toxin impairs clearance in mice. Infect Immun (2011) 0.81
GPI-anchored diphtheria toxin receptor allows membrane translocation of the toxin without detectable ion channel activity. EMBO J (1996) 0.80
In vitro intracellular trafficking of virulence antigen during infection by Yersinia pestis. PLoS One (2009) 0.80
Anti-idiotypic antibodies that protect cells against the action of diphtheria toxin. Proc Natl Acad Sci U S A (1989) 0.77
Endocytosis and the recycling of plasma membrane. J Cell Biol (1983) 10.24
Diphtheria toxin. Annu Rev Biochem (1977) 8.44
pH and the recycling of transferrin during receptor-mediated endocytosis. Proc Natl Acad Sci U S A (1983) 8.41
Effect of weak bases on the intralysosomal pH in mouse peritoneal macrophages. J Cell Biol (1981) 6.63
Recycling receptors: the round-trip itinerary of migrant membrane proteins. Cell (1983) 5.99
Receptor-mediated endocytosis of transferrin and the uptake of fe in K562 cells: identification of a nonlysosomal acidic compartment. Proc Natl Acad Sci U S A (1982) 5.74
Penetration of Semliki Forest virus from acidic prelysosomal vacuoles. Cell (1983) 5.46
Weak bases and ionophores rapidly and reversibly raise the pH of endocytic vesicles in cultured mouse fibroblasts. J Cell Biol (1982) 5.11
Diphtheria toxin entry into cells is facilitated by low pH. J Cell Biol (1980) 4.62
Diphtheria toxin fragment forms large pores in phospholipid bilayer membranes. Proc Natl Acad Sci U S A (1981) 4.28
One molecule of diphtheria toxin fragment A introduced into a cell can kill the cell. Cell (1978) 4.06
Surface distribution and recycling of the low density lipoprotein receptor as visualized with antireceptor antibodies. J Cell Biol (1982) 2.84
Inhibition of coated pit formation in Hep2 cells blocks the cytotoxicity of diphtheria toxin but not that of ricin toxin. J Cell Biol (1985) 2.71
Intracellular dissociation of receptor-bound asialoglycoproteins in cultured hepatocytes. A pH-mediated nonlysosomal event. J Biol Chem (1983) 2.45
Entry of the toxic proteins abrin, modeccin, ricin, and diphtheria toxin into cells. II. Effect of pH, metabolic inhibitors, and ionophores and evidence for toxin penetration from endocytotic vesicles. J Biol Chem (1982) 2.32
Membrane fusion mutants of Semliki Forest virus. J Cell Biol (1984) 2.27
Receptor-mediated internalization of Pseudomonas toxin by mouse fibroblasts. Cell (1980) 2.17
Association of diphtheria toxin with Vero cells. Demonstration of a receptor. J Biol Chem (1978) 2.13
The asialoglycoprotein receptor internalizes and recycles independently of the transferrin and insulin receptors. Cell (1983) 2.10
Receptor-mediated internalization and degradation of diphtheria toxin by monkey kidney cells. J Biol Chem (1979) 1.94
Receptor-mediated endocytosis of diphtheria toxin by cells in culture. Proc Natl Acad Sci U S A (1982) 1.59
The avidin-biotin complex in affinity cytochemistry. Methods Enzymol (1979) 1.53
Endocytosis: a review of mechanisms and plasma membrane dynamics. Biochem J (1983) 1.33
Evidence for penetration of diphtheria toxin to the cytosol through a prelysosomal membrane. Infect Immun (1984) 1.17
Receptor-mediated entry of Pseudomonas toxin: methylamine blocks clustering step. Infect Immun (1983) 1.15
Kinetics of adenosinediphosphoribosylation of elongation factor 2 in cells exposed to diphtheria toxin. Infect Immun (1981) 1.11
Methylamine stimulates the action of ricin toxin but inhibits that of diphtheria toxin. J Biol Chem (1981) 1.10
Evidence that diphtheria toxin and modeccin enter the cytosol from different vesicular compartments. J Cell Biol (1984) 1.08
Effect of potassium depletion of cells on their sensitivity to diphtheria toxin and pseudomonas toxin. J Cell Physiol (1985) 1.05
Evidence for pseudomonas exotoxin A receptors on plasma membrane of toxin-sensitive lm fibroblasts. Infect Immun (1984) 0.97
Requirements for the translocation of diphtheria toxin fragment A across lipid membranes. J Biol Chem (1985) 0.93
Visualization of intracellular trafficking: use of biotinylated ligands in conjunction with avidin-gold colloids. J Histochem Cytochem (1984) 0.92
Essential role of calcium in cellular internalization of Pseudomonas toxin. Infect Immun (1982) 0.91
Diphtheria toxin does not enter resistant cells by receptor-mediated endocytosis. Infect Immun (1983) 0.90
Fate of tetanus toxin bound to the surface of primary neurons in culture: evidence for rapid internalization. J Cell Biol (1985) 0.86
Uptake of diphtheria toxin and its fragment A moiety by mammalian cells in culture. Infect Immun (1976) 0.85
The protective mechanism of action of amines in diphtheria toxin treated Vero cells. Can J Microbiol (1982) 0.81
Toxic ligand conjugates as tools in the study of receptor-ligand interactions. J Cell Biochem (1982) 0.78
Combined use of immunoferritin and immunocolloidal gold for the simultaneous demonstration of two antigens by immuno-electron microscopy. Stain Technol (1982) 0.78
Shigella infection of Henle intestinal epithelial cells: role of the bacterium. Infect Immun (1979) 5.24
Shigella infection of henle intestinal epithelial cells: role of the host cell. Infect Immun (1979) 5.09
Role of exotoxin and protease as possible virulence factors in experimental infections with Pseudomonas aeruginosa. Infect Immun (1978) 3.15
The alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein binds and internalizes Pseudomonas exotoxin A. J Biol Chem (1992) 2.40
Altered surfactant function and structure in SP-A gene targeted mice. Proc Natl Acad Sci U S A (1996) 2.29
Studies on the mode of action of diphtheria toxin. I. Protein synthesis in guinea pig tissues. J Exp Med (1966) 2.22
Receptor-mediated internalization of Pseudomonas toxin by mouse fibroblasts. Cell (1980) 2.17
Production of staphylococcal enterotoxin F and pyrogenic exotoxin C by Staphylococcus aureus isolates from toxic shock syndrome-associated sources. Infect Immun (1983) 2.08
Experimental studies on the pathogenesis of infections due to Pseudomonas aeruginosa: direct evidence for toxin production during Pseudomonas infection of burned skin tissues. J Infect Dis (1977) 1.84
The epidemiology of serious eye injuries from the United States Eye Injury Registry. Graefes Arch Clin Exp Ophthalmol (2000) 1.81
Anomalous high native resistance to athymic mice to bacterial pathogens. Infect Immun (1977) 1.75
Mechanism of action for leflunomide in rheumatoid arthritis. Clin Immunol (1999) 1.72
Elimination of Leishmania donovani amastigotes by activated macrophages. Infect Immun (1981) 1.58
Phagocytosis and intracellular killing of Staphylococcus aureus by normal mouse peritoneal macrophages. Infect Immun (1975) 1.57
Comparison of the effects of tacrolimus and cyclosporine on the pharmacokinetics of mycophenolic acid. Ther Drug Monit (2001) 1.53
Effects of cyclosporin, FK506, and rapamycin on graft-vessel disease. Lancet (1991) 1.49
Enhanced metabolism of Leishmania donovani amastigotes at acid pH: an adaptation for intracellular growth. Science (1985) 1.48
In vitro and in vivo activity and cross resistance profiles of novel ruthenium (II) organometallic arene complexes in human ovarian cancer. Br J Cancer (2002) 1.45
Newer immunosuppressive drugs: a review. J Am Soc Nephrol (1999) 1.43
Studies on the mode of action of diphtheria toxin. III. Effect on subcellular components of protein synthesis from the tissues of intoxicated guinea pigs and rats. J Exp Med (1970) 1.40
Chemical modulation of diphtheria toxin action on cultured mammalian cells. Infect Immun (1975) 1.37
The transforming growth factor-betas. A new family of immunoregulatory molecules. Ann N Y Acad Sci (1990) 1.36
Cell cycle protein expression in vascular smooth muscle cells in vitro and in vivo is regulated through phosphatidylinositol 3-kinase and mammalian target of rapamycin. Arterioscler Thromb Vasc Biol (2001) 1.36
A role for oxygen-dependent mechanisms in killing of Leishmania donovani tissue forms by activated macrophages. J Immunol (1982) 1.36
Interaction of cultured mammalian cells with [125I] diphtheria toxin. Infect Immun (1975) 1.34
Lethal toxin of Bacillus cereus. I. Relationships and nature of toxin, hemolysin, and phospholipase. J Bacteriol (1967) 1.32
Evolving techniques in the treatment of macular detachment caused by optic nerve pits. Ophthalmology (1988) 1.32
The epidemiology of genital colonization with Staphylococcus aureus. Ann Intern Med (1982) 1.32
The effect of neutral and acidic polysaccharides on natural resistance of mice to bacterial challenge. J Infect Dis (1965) 1.32
AnkB, a periplasmic ankyrin-like protein in Pseudomonas aeruginosa, is required for optimal catalase B (KatB) activity and resistance to hydrogen peroxide. J Bacteriol (2000) 1.31
Studies on the mode of action of diphtheria toxin. II. Protein synthesis in primary heart cell cultures. J Exp Med (1967) 1.31
Mutants of staphylococcal toxic shock syndrome toxin 1: mitogenicity and recognition by a neutralizing monoclonal antibody. Infect Immun (1990) 1.31
Rapid screening assay for toxic shock syndrome toxin production by Staphylococcus aureus. J Clin Microbiol (1984) 1.31
Molecular mechanisms of action of new xenobiotic immunosuppressive drugs: tacrolimus (FK506), sirolimus (rapamycin), mycophenolate mofetil and leflunomide. Curr Opin Immunol (1996) 1.31
Rapamycin reverses chronic graft vascular disease in a novel cardiac allograft model. Circulation (1999) 1.30
Pseudomonas exotoxin-mediated selection yields cells with altered expression of low-density lipoprotein receptor-related protein. J Cell Biol (1995) 1.29
Immunoregulatory role of transforming growth factor beta (TGF-beta) in development of killer cells: comparison of active and latent TGF-beta 1. J Exp Med (1990) 1.28
Antibody responses to toxic-shock-syndrome (TSS) toxin by patients with TSS and by healthy staphylococcal carriers. J Infect Dis (1984) 1.28
Autoradiographic evidence for the impermeability of mouse peritoneal macrophages to tritiated streptomycin. J Bacteriol (1967) 1.27
Phagocytosis and intracellular disposition of viable bacteria by the isolated perfused rat liver. J Reticuloendothel Soc (1965) 1.26
Status of bacterial toxins and their nomenclature: need for discipline and clarity of expression. Bacteriol Rev (1967) 1.23
Rapamycin inhibits arterial intimal thickening caused by both alloimmune and mechanical injury. Its effect on cellular, growth factor, and cytokine response in injured vessels. Transplantation (1993) 1.22
Killing of intraphagocytic Staphylococcus aureus by dihydrostreptomycin entrapped within liposomes. Antimicrob Agents Chemother (1978) 1.20
Globe perforation from peribulbar injection. Arch Ophthalmol (1987) 1.17
Enhancement of carrier-mediated transport after immunologic activation of peritoneal macrophages. J Immunol (1977) 1.16
Receptor-mediated entry of Pseudomonas toxin: methylamine blocks clustering step. Infect Immun (1983) 1.15
Visceral leishmaniasis in congenic mice of susceptible and resistant phenotypes: immunosuppression by adherent spleen cells. Infect Immun (1985) 1.15
Stanford experience with obliterative bronchiolitis after lung and heart-lung transplantation. Ann Thorac Surg (1996) 1.10
Synergistic induction of interleukin-1 by endotoxin and toxic shock syndrome toxin-1 using rat macrophages. Infect Immun (1987) 1.09
Facilitated uptake of streptomycin by Kupffer cells during phagocytosis. Nature (1967) 1.09
Regulation of the macrophage vacuolar ATPase and phagosome-lysosome fusion by Histoplasma capsulatum. J Immunol (1999) 1.07
Cell-mediated immune phenomena induced by lymphokines from splenic lymphocytes of mice with chronic staphylococcal infection. Infect Immun (1975) 1.07
Localization of ClC-2 Cl- channels in rabbit gastric mucosa. Am J Physiol Cell Physiol (2001) 1.06
The role of respiratory epithelium in a rat model of obliterative airway disease. Transplantation (2000) 1.06
Comparison of the in vitro metabolism of the macrolide immunosuppressants sirolimus and RAD. Transplant Proc (2001) 1.06
Vitrectomy in asteroid hyalosis. Retina (1990) 1.05
Inhibition of protein synthesis after intravenous or intramuscular challenge with diphtheria toxin. Infect Immun (1972) 1.05
Dental caries experience of disabled children and young adults in Kuwait. Community Dent Health (2001) 1.04
Enhanced phagocytosis, killing, and serum sensitivity of Escherichia coli and Staphylococcus aureus treated with sub-MICs of imipenem. Antimicrob Agents Chemother (1988) 1.04
Efficacy of combined immunostimulation and chemotherapy in experimental visceral Leishmaniasis. Am J Trop Med Hyg (1983) 1.02
Therapeutic monitoring of mycophenolic acid. A consensus panel report. Clin Biochem (1998) 1.01
Histoplasma capsulatum yeasts are phagocytosed via very late antigen-5, killed, and processed for antigen presentation by human dendritic cells. J Immunol (2001) 1.00
Cultural, phagocytic, and bactericidal characteristics of peritoneal macrophages. J Reticuloendothel Soc (1973) 1.00
Technics for fiberoptic laryngoscopy in anesthesia. Anesth Analg (1974) 1.00
Binding and uptake of pulmonary surfactant protein (SP-A) by pulmonary type II epithelial cells. J Histochem Cytochem (1989) 1.00
Reduced temperature alters Pseudomonas exotoxin A entry into the mouse LM cell. Infect Immun (1986) 1.00
Differential effects of glucocorticoid on expression of surfactant proteins in a human lung adenocarcinoma cell line. Biochim Biophys Acta (1988) 0.99
Crystal structure of a biologically inactive mutant of toxic shock syndrome toxin-1 at 2.5 A resolution. Protein Sci (1996) 0.98
Association of down-regulation of cytokine activity with rat hind limb allograft survival. Transplantation (1995) 0.97
Evidence for pseudomonas exotoxin A receptors on plasma membrane of toxin-sensitive lm fibroblasts. Infect Immun (1984) 0.97
Biological activity of toxic shock syndrome toxin 1 and a site-directed mutant, H135A, in a lipopolysaccharide-potentiated mouse lethality model. Infect Immun (1995) 0.96
Normal surfactant pool sizes and inhibition-resistant surfactant from mice that overexpress surfactant protein A. Am J Respir Cell Mol Biol (1999) 0.96
Isolation and characterization of Pseudomonas aeruginosa exotoxin A binding glycoprotein from mouse LM cells. J Biol Chem (1991) 0.96
Protection of rabbits in an infection model of toxic shock syndrome (TSS) by a TSS toxin-1-specific monoclonal antibody. Infect Immun (1988) 0.96
Treatment with rapamycin and mycophenolic acid reduces arterial intimal thickening produced by mechanical injury and allows endothelial replacement. Transplantation (1995) 0.96
Immunosuppressants: cellular and molecular mechanisms of action. Am J Kidney Dis (1996) 0.94
PIG3V, an immortalized human vitiligo melanocyte cell line, expresses dilated endoplasmic reticulum. In Vitro Cell Dev Biol Anim (2000) 0.93
Studies on the mode of action of diphtheria toxin. V. Protein metabolism in a guinea pig model simulating chronic diphtheritic toxemia. Infect Immun (1973) 0.93
Absorption of botulinal toxin from the gastrointestinal tract. Rev Infect Dis (1980) 0.93
Interaction of pseudomonas exoproducts with phagocytic cells. Can J Microbiol (1982) 0.93
Visualization of intracellular trafficking: use of biotinylated ligands in conjunction with avidin-gold colloids. J Histochem Cytochem (1984) 0.92
Effects of humanized monoclonal antibody to rhesus CD11a in rhesus monkey cardiac allograft recipients. Transplantation (2000) 0.92
Ocular self-mutilation. Ann Ophthalmol (1989) 0.92
Essential role of calcium in cellular internalization of Pseudomonas toxin. Infect Immun (1982) 0.91
Synergistic effect of glucantime and a liposome-encapsulated muramyl dipeptide analog in therapy of experimental visceral leishmaniasis. Infect Immun (1985) 0.91
Visceral leishmaniasis in congenic mice of susceptible and resistant phenotypes: T-lymphocyte-mediated immunosuppression. Infect Immun (1985) 0.90
Diphtheria toxin does not enter resistant cells by receptor-mediated endocytosis. Infect Immun (1983) 0.90